High materiality7/10
Jazz Pharmaceuticals price target raised to $270 from $260 at Barclays
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises JAZZ target to $270 from $260; posted price $251.58.
- Barclays raises JAZZ target to $270; price $251.58.
Key facts
- 01
Target: $270
- 02
Posted price: $251.58
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.